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Bullous pemphigoid (BP) is the most common
autoimmune subepidermal vesiculobullous disease
usually affecting older patients.1 In BP, there is no
ethnic or racial predilection and it affects both men
and women equally.2-5 Based on the reported data
in the Philippine Dermatological Society Health
Information System, the incidence of BP for 2014 is
0.0009 per 100,000,6 which is low compared with the
0.2 to 3 per 100,000 in developed countries such as
the United Kingdom.7 Precipitating factors include
intake of drugs such as furosemide, phenacetin,
enalapril, and ibuprofen; radiation therapy; ultra-
violet A and B exposure; burns; surgery; and organ
transplantation.8 BP is typically characterized by
mild to intractable pruritic macules, patches, and
plaques (urticarial stage) eventually evolving into
tense serous or hemorrhagic vesicles and bullae with
excoriations and erosions (bullous stage) typically
seen on flexural areas, lower abdomen, and lower
extremities.1 Nikolsky and Asboe-Hansen signs are
usually negative.9 In some cases, BP presents clini-
cally as atypical variants including dyshidrosiform
and intertrigolike, prurigo nodulariselike, eczema-
tous, localized, and erythrodermic forms.10-18 In
addition to these atypical presentations, BP may be
seen on seborrheic areas (scalp, pre- and
postauricular, auricular, chest) and is referred to as
seborrheic pemphigoid, which has very few reported
cases.19 Here, we report a case of seborrheic
pemphigoid in a 67-year-old Filipino man.
CASE REPORT
We present a case of a 67-year-old Filipino man
who is hypertensive, diabetic, and dyslipidemic
who is on the following maintenance medications:
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Case Reports 2016;2:80-3.aspirin, and simvastatin for more than 5 years. He
had no history of seborrheic dermatitis. He pre-
sented with a 4-week history of erythematous,
severely pruritic, recurrent macules and patches on
the cheeks and chest topped with clear fluid-filled
vesicles and bullae spreading to the pre- and post-
auricular areas, mandibular areas, and scalp. A few
scattered lesions also appeared on the arms and
thighs. Persistence of the lesions prompted a visit to
the outpatient department of a tertiary hospital in
Makati City, Philippines. Physical examination found
a few tense, clear fluid-filled vesicles and bullae on
the right preauricular area, chest, and sole of the right
foot (Fig 1). Several erythematous erosions were also
noted on the scalp, pre- and post-auricular areas,
malar areas, mandible, and chest, with a few on the
arms and thighs (Fig 2). Nikolsky and Asboe-Hansen
signs were negative. No other significant skin or
mucosal lesions were appreciated.
A 4-mm skin punch biopsy specimen from the
edge of the blister on the chest was submitted
for histologic examination (hematoxylin-eosin
stain), which found a subepidermal blister with a
superficial perivascular lymphohistiocytic and
eosinophilic infiltrate (Fig 3). Direct immunofluores-
cence of perilesional skin from the chest showed
linear deposits of IgG (11) and C3 (12) in
the basement membrane zone (Fig 4). Serum
enzyme-linked immunosorbent assay to BP180 was
positive at 73.45 (cutoff value for positivity, 9 U/mL).
Based on the clinical distribution and histologic and2352-5126
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Fig 1. Few tense, clear, fluid-filled vesicles and bullae on the (A) right preauricular area,
(B) chest, and (C) sole of right foot.
Fig 2. Erythematous erosions on the (A) scalp, (B) malar areas and mandible, (C) pre- and
postauricular areas, and (D and E) a few on the thighs.
JAAD CASE REPORTS
VOLUME 2, NUMBER 1
Castro-Fores et al 81immunologic findings, seborrheic pemphigoid
was diagnosed. Treatment with prednisone at a
low dose of 0.2 mg/kg/d (gradually tapered),
together with niacin, 1500 mg/d, and doxycycline,
200 mg/d, produced significant improvement
with clearing of lesions and symptoms. After 7weeks,
the patient achieved complete remission and has
stayed clear for 2 months with no maintenance
medications.DISCUSSION
Seborrheic pemphigoid (SP) is a very rare variant of
BPwith only 4 cases reported in the literature. The first
reported case was an elderly woman described by
Schynder in 1969. SP is characterized by vesicles,
bullae, and erosions involving the seborrheic areas of
the body.19,20 Goldberg et al21 found that in BP,
expression of the BP antigens was variable, with
greatest levels on sites of predilection and lowest
Fig 4. IgG direct immunofluorescence of perilesional skin shows linear deposits of (A) IgG
(11) and (B) C3 (12) in the basement membrane zone.
Fig 3. Subepidermalblister (asterisk)with superficial perivascular lymphohistiocytic (yellow triangle)
and eosinophilic infiltrate (blue triangle). (Hematoxylin-eosin stain; original magnification:320.)
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possible that expression of BP antigens is high at the
seborrheic areas producing the typical vesicles and
bullae. Other findings suggest that the presence of
Malassezia and the excess sebum production on
seborrheic areas may contribute to the development
of SP via koebnerization, acting as a trigger for the
disease. In addition, Malassezia is known to activate
the classical or alternative complement pathways,
possibly augmenting the complement-mediated
inflammation seen in typical BP.19,20 Because of
the rarity of this disease, there are no specific
established treatment regimens. However, according
to Errichetti et al,19 treatment with low-dose systemic
corticosteroids is effective in SP. Our patient started
oral prednisone at 0.2 mg/kg/d with a subsequent
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